azacitidine has been researched along with ivosidenib in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 11 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carraway, HE; Chandhok, NS; Griffiths, EA; Prebet, T | 1 |
| Choe, S; Daigle, S; de Botton, S; DiNardo, CD; Döhner, H; Fan, B; Fathi, AT; Frankfurt, O; Franovic, A; Frattini, MG; Gianolio, DA; Goldwasser, M; Gong, J; Kantarjian, HM; Lersch, F; Martinelli, G; Patel, PA; Raffoux, E; Schuh, AC; Stein, AS; Stein, EM; Stone, RM; Tan, P; Vyas, P; Winkler, T; Wu, B; Zeidan, AM; Zhang, V | 1 |
| Bertani, G; Calado, RT; Daigle, SR; de Botton, S; Döhner, H; Gianolio, DA; Heuser, M; Hui, J; Montesinos, P; Pandya, SS; Recher, C; Schuh, AC; Vives, S; Wang, J; Yeh, SP; Zarzycka, E | 1 |
| Briceño-Casado, MP; Gil-Sierra, MD; Sierra-Sanchez, JF | 1 |
| Goodman, AM; Mohyuddin, GR; Prasad, V | 1 |
| de Botton, S; Döhner, H; Montesinos, P | 1 |
| Bewersdorf, JP; Goshua, G; Huntington, SF; Patel, KK; Podoltsev, NA; Shallis, RM; Stahl, M; Stein, EM; Zeidan, AM | 1 |
| Takahashi, K | 1 |
| Borthakur, G; Bose, P; Daver, NG; DiNardo, CD; Duose, DY; Garcia, JS; Garcia-Manero, G; Jabbour, EJ; Jakobsen, NA; Kadia, TM; Kantarjian, H; Kim, YJ; Konopleva, M; Lachowiez, CA; Loghavi, S; Luskin, MR; Masarova, L; Ravandi, F; Short, NJ; Takahashi, K; Tanaka, T; Tidwell, RSS; Tippett, GD; Turkalj, S; Uryu, H; Vyas, P; Zeng, Z | 1 |
| Gastaud, L; Mechelfekh, Y | 1 |
1 review(s) available for azacitidine and ivosidenib
| Article | Year |
|---|---|
Advances in non-intensive chemotherapy treatment options for adults diagnosed with acute myeloid leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Cytarabine; Decitabine; Gemtuzumab; Glycine; Humans; Leukemia, Myeloid, Acute; Male; Molecular Targeted Therapy; Phenylurea Compounds; Precision Medicine; Pyridines; Recurrence; Remission Induction; Staurosporine; Sulfonamides | 2020 |
3 trial(s) available for azacitidine and ivosidenib
| Article | Year |
|---|---|
Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia.
Topics: Aged; Aged, 80 and over; Apoptosis; Azacitidine; Drug Therapy, Combination; Enzyme Inhibitors; Female; Glycine; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Male; Middle Aged; Pyridines | 2021 |
Ivosidenib and Azacitidine in
Topics: Antineoplastic Agents; Azacitidine; Febrile Neutropenia; Glycine; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Leukopenia; Pyridines; Recurrence | 2022 |
A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid Malignancies.
Topics: Antineoplastic Agents; Azacitidine; Humans; Isocitrate Dehydrogenase; Neoplasm Recurrence, Local | 2023 |
7 other study(ies) available for azacitidine and ivosidenib
| Article | Year |
|---|---|
Ivosidenib Boosts OS with Azacitidine in AML.
Topics: Azacitidine; Glycine; Humans; Leukemia, Myeloid, Acute; Pyridines | 2022 |
Ivosidenib and Azacitidine in IDH1-Mutated AML.
Topics: Azacitidine; Glycine; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Pyridines | 2022 |
Ivosidenib and Azacitidine in IDH1-Mutated AML.
Topics: Azacitidine; Glycine; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Pyridines | 2022 |
Ivosidenib and Azacitidine in IDH1-Mutated AML. Reply.
Topics: Azacitidine; Glycine; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Pyridines | 2022 |
Cost-effectiveness of azacitidine and ivosidenib in newly diagnosed older, intensive chemotherapy-ineligible patients with
Topics: Azacitidine; Cost-Benefit Analysis; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Pyridines; Quality-Adjusted Life Years; United States | 2023 |
Is Induction of Hypomethylation with Ivosidenib and 5-Azacitidine Curative Regimen against IDH1-Mutated Acute Myeloid Leukemia?
Topics: Azacitidine; Glycine; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Mutation; Pyridines | 2023 |
[Ivosidenib-azacitidine in acute myeloid leukemia with IDH1R132 mutation].
Topics: Azacitidine; Humans; Leukemia, Myeloid, Acute; Mutation; Pyridines | 2023 |